Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

MIST with PRF versus GBT (with or without PRF) for treating a single deep intrabony periodontal defect

Official title: Comparison of Minimally Invasive Surgical Therapy in Combination With Platelet Rich Fibrine and Guided Biofilm Therapy Combined With Platelet Rich Fibrine in the Treatment of Solitaire Intrabony Periodontal Defect A Prospective RCT.

Run by Semmelweis University · NCT06768424 · Data updated 2026-11-12

This trial tests whether adding platelet-rich fibrin (PRF) to a minimally invasive surgical approach (MIST) or to guided biofilm therapy (GBT) improves healing of a single deep intrabony periodontal defect in adults.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment36 (estimated)
SponsorSemmelweis University
Academic / other
Locations1 site (Budapest, Budapest)
StatusRecruiting
StartedDecember 20, 2023
Main results expectedJune 30, 2027
Study endsDecember 20, 2027
Registry record updatedApril 28, 2026
Trial IDNCT06768424 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with a single intrabony periodontal defect of at least 4 mm, good oral hygiene (FMPS/FMBS <15%), light or non-smokers, no furcation involvement, and able to attend follow-up visits and give informed consent.

Probably not a fit

Patients with multiple or complex defects (for example steep defect angulation >25°), significant furcation involvement, poor oral hygiene, heavy smoking, or inability to attend follow-up are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized controlled trial that enrolls adults with a solitary intrabony defect ≥4 mm and randomizes them to three arms: GBT alone (control), non-surgical GBT with PRF placed into the cleaned defect, or MIST with PRF placed after flap access. Clinical periodontal parameters are recorded at baseline and at six months and standardized radiographs are taken at six months to measure bone changes. The primary outcome is the change in clinical attachment level (delta CAL) at six months, with radiographic bone fill and standard clinical measures as secondary outcomes. Key eligibility includes good oral hygiene, low plaque and bleeding scores, minimal smoking, and no furcation involvement.

Why it matters

Potential benefit: If successful, this approach could increase attachment gain and bone fill and may allow some patients to avoid more extensive surgery.

How similar studies have gone: Prior studies have shown favorable results for PRF and for minimally invasive surgical techniques in periodontal regeneration, but placing PRF without flap access is less well established and direct comparisons are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* solitaire intrabony periodontal defect at least 4 mm

Exclusion Criteria:

* Periodontitis with intrabony defect (Intrabony component ≥ 4mm, defect radiological angulation \> 25°,
* The patient is able to comply with the study -related procedures (i.e. good level of oral hygiene, follow-up procedures).
* Patients must not be heavy smokers (\<5 cigarettes/day).
* furcation involvement
* Full mouth plaque and bleeding scores (FMPS and FMBS) of \<15% (O'Leary et al. 1972).
* The patient is able to fully understand the nature of the study, signed informed consent.

Where it's running

  • Semmelweis University Department of Periodontology
    Budapest, Budapest, Hungary
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.